arrow
Y

Yasushi Onishi

jikei university
H指数:30
被引数:6,912

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial
2026-01-010
OAAI
Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia

异基因造血干细胞移植治疗获得性纯红细胞再生障碍的结局

2025-12-010
PRE
Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

贝洛莫斯迪克作为糖皮质激素依赖/难治性cGVHD的二线或后线治疗方案的长期能随访:一项日本研究中的临床结局

2025-11-260
OAAI
High-risk HLA mismatch combinations responsible for severe acute graft-versus-host disease in cord blood transplantation

高危HLA错配组合是导致脐带血移植中严重急性移植物抗宿主病的原因

2025-10-030
PRE
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT

甲氨蝶呤给药方案对HLA匹配异基因造血干细胞移植中GVHD预防的临床结局的影响

2025-10-010
OAAI
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia

易丢失的HLA I类等位基因揭示了获得性再生障碍性贫血早期造血细胞移植的结局

2025-09-050
PRE
Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan

单份无关脐带血移植后的早期死亡率近年来是否有所改善?——日本2003年至2022年全国登记数据分析

2025-08-160
OA
Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study

治疗相关性和新生急性早幼粒细胞白血病患者异基因造血干细胞移植的比较分析回顾性研究

2025-03-310
OAAI
Efficacy and Safety of Eltrombopag Added to Rabbit Anti-Human Thymocyte Globulin plus Cyclosporine in Aplastic Anemia: Results from a Prospective Multicenter Phase II Study

Eltrombopag联合兔抗人胸腺细胞球蛋白与环孢素治疗再生障碍性贫血的疗效与安全性:一项前瞻性多中心II期研究的结果

BLOOD
IF23.1
2024-11-050
PRE
Frequent Loss of HLA-B*40:02 from Leukocytes in Male Patients with Hepatitis-Associated Aplastic Anemia

男性肝炎相关性再生障碍性贫血患者中白细胞中HLA-B*40:02的频繁丢失

BLOOD
IF23.1
2024-11-050
PRE
Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor

细胞因子调节与接受Nuvisertib(TP-3654)治疗骨髓纤维化患者的症状改善显著相关,Nuvisertib是一种在研的选择性PIM1激酶抑制剂。

BLOOD
IF23.1
2024-11-050
PRE
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

异基因造血干细胞移植后新生慢性粒细胞白血病急变期与费城染色体阳性急性淋巴细胞白血病的比较

CANCER
IF5.1
2024-11-041
PRE
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia

成人再生障碍性贫血患者异基因造血干细胞移植前中性粒细胞绝对计数的意义

2024-05-162
PRE
Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens
2024-03-010
PRE
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia

单倍体相合干细胞移植后环磷酰胺与脐血移植治疗再生障碍性贫血的比较

2023-12-015
PRE